Skip to main content
. 2021 Apr 19;6(1):48–58. doi: 10.1159/000514727

Table 1.

Patients' and HVs' baseline clinical characteristics

Patient 1 Patient 2 HVs (n = 10)
Age, years 60 60 56.1 (9.0)
Gender Male Female 5 female, 5 male
Weight, kg 80 56 76.1 (5.2)
Height, cm 178 161 174.4 (23.2)
BMI, kg/m2 25.2 21.6 24.8 (4.4)
Comorbidities
 Type 2 diabetes Yes No No
 Hypertension Yes No No
 Other No No No
Temperature, °C 36.9 36.3 36.1 (0.4)
O2 saturation, % 89 91 96.8 (3.1)
Ferritin, ng/mL 550 653 215 (42.1)
Lactate, nmol/L 3.1 2 0.8 (0.3)
LDH, IU/L 289 350 258 (37)
GOT, IU/L 20 55 32 (9.7)
GPT, IU/L 25 75 36 (7.4)
pH 7.41 7.44 7.41 (0.2)
CRP, mg/L 9.8 7.9 5.6 (3.8)
MBP, mm Hg 75 75 73 (12)
SBP, mm Hg 125 123 125 (10)
Heart rate, bpm 105 111 87 (14)
Respiratory rate, brpm 28 28 15 (4)
Pneumonia at admission Yes Yes No
qSOFA score 1 1
CGS score 15 15
SARS-CoV-2 (RT-PCR) Positive Positive Negative

Values for HVs denote mean (SD). bpm, beats per minute; BMI, body mass index; brpm, breaths per minute; GCS, Glasgow Coma Score; CRP, C-reactive protein; GOT, glutamic oxaloacetic transaminase; GPT, glutamic-pyruvic transaminase; HV, healthy volunteer; LDH, lactate dehydrogenase; MBP, mean blood pressure; qSOFA, quick Sequential Organ Failure Assessment; SBP, systolic blood pressure; SD, standard deviation.